Canada Markets open in 1 hr 52 mins

Emerald Health Therapeutics, Inc. (EMHTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0480+0.0005 (+1.05%)
At close: 03:34PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.0475
Open0.0470
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0470 - 0.0507
52 Week Range0.0400 - 0.4660
Volume11,160
Avg. Volume262,104
Market Cap10.949M
Beta (5Y Monthly)0.78
PE Ratio (TTM)N/A
EPS (TTM)-0.1260
Earnings DateNov. 29, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Emerald Health Therapeutics Sells Patents to FlowerPod

    Vancouver, British Columbia--(Newsfile Corp. - January 11, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has entered into a binding term sheet to sell to FlowerPod LLC all patents and related intellectual property pertaining to Emerald's vaporizer cannabis puck concept in exchange for US$1 million in cash and a US$500,000 one-year interest-bearing secured promissory note. As part of the transaction, Emerald will transfer its ownership interest back to FlowerPod

  • Baystreet

    Stocks in play: Emerald Health Therapeutics Inc

    Announced the results of voting at its annual general meeting held December 30, 2021. Shareholders voted ...

  • Newsfile

    Emerald Health Therapeutics Reports 2021 AGM Results

    Vancouver, British Columbia--(Newsfile Corp. - December 31, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has announced the results of voting at its annual general meeting held December 30, 2021. Shareholders voted in favour of all resolutions, setting the number of directors at three, electing Jim Heppell, Punit Dhillon and Bobby Rai as directors, and appointing MNP LLP as auditors of the Company for the ensuing year and authorizing the directors ...